Chen Hengxi, Xiong Wei, Zeng Yuhua, Du Haihong, Ye Lin, Chen Liang, Chen Jia, Liu Yana, Gong Meiqin, Dong Xue, Liu Jie, Tan Xin
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Ann Transl Med. 2022 Nov;10(22):1217. doi: 10.21037/atm-22-4988.
The electrothermal effect of hysteroscopic bipolar electrosurgical resection may cause damage to the endometrium, leading to intrauterine adhesion (IUA). Although some studies have demonstrated the efficacy and feasibility of auto-cross-linked hyaluronic (ACP) gel in preventing IUAs, controversy over its use continues. In this randomized controlled multi-center 2-arm parallel trial, we aimed to examine the efficacy and safety of ACP gel in preventing IUA after hysteroscopic electrosurgical resection and facilitate pregnancy in patients.
Patients from 4 centers in China were randomly assigned (1:1) to receive an intrauterine infusion of ACP gel or nothing after hysteroscopic electrosurgical resection. The randomization assignment was generated by computer and kept in a sealed envelope. A second-look hysteroscopy was performed within 3 months of the surgery.
From June 2018 to May 2021, 200 patients were recruited. Ultimately, 82 patients in both groups were included in the result analysis. The baseline characteristics were comparable. The outcomes were assessed by using per-protocol analysis. The incidence of IUA in the ACP gel group was lower than that in the control group [3.66% 10.98%, risk ratio (RR) =0.333, 95% confidence interval (CI): 0.094-1.187, P=0.072], and the planned pregnancy rate was higher than that of the control group (60.98% 40.54%, RR =1.504, 95% CI: 0.949-2.384, P=0.071), but the difference was not statistically significant. There was no significant difference in menstruation change. Menstrual volume remained unchanged in most cases (86.59% in ACP gel group 89.02% in the control group, RR =0.877, 95% CI: 0.877-1.109, P=0.815). Menstrual volume decreased in 10 women in the ACP gel group and 8 in the control group (12.20% 9.76%, RR =1.250, 95% CI: 0.520-3.007, P=0.617). No adverse effects were observed after the ACP administration.
The present study showed that the use of ACP gel appeared to reduce both the tendency of IUA and American Fertility Society (AFS) scores and improve the subsequent pregnancy rate during hysteroscopic electrosurgical resection when treating polyps, fibroids, and uterine septum. ACP might be recommended to prevent IUA after such surgery. Further studies should be conducted with larger numbers of participants.
Chinese Clinical Trial Registry ChiCTR2100047165.
宫腔镜下双极电切术的电热效应可能会损伤子宫内膜,导致宫腔粘连(IUA)。尽管一些研究已证实自交联透明质酸(ACP)凝胶预防宫腔粘连的有效性和可行性,但关于其使用仍存在争议。在这项随机对照多中心双臂平行试验中,我们旨在研究ACP凝胶在宫腔镜电切术后预防宫腔粘连及促进患者妊娠方面的有效性和安全性。
来自中国4个中心的患者在宫腔镜电切术后被随机(1:1)分配接受宫腔内注入ACP凝胶或不做处理。随机分组由计算机生成并保存在密封信封中。在术后3个月内进行二次宫腔镜检查。
2018年6月至2021年5月,共招募了200例患者。最终,两组各82例患者纳入结果分析。基线特征具有可比性。采用符合方案分析评估结局。ACP凝胶组的宫腔粘连发生率低于对照组[3.66%对10.98%,风险比(RR)=0.333,95%置信区间(CI):0.094 - 1.187,P = 0.072],计划妊娠率高于对照组(60.98%对40.54%,RR = 1.504,95% CI:0.949 - 2.384,P = 0.071),但差异无统计学意义。月经变化无显著差异。大多数情况下月经量保持不变(ACP凝胶组为86.59%,对照组为89.02%,RR = 0.877,95% CI:0.877 - 1.109,P = 0.815)。ACP凝胶组有10名女性月经量减少,对照组有8名女性月经量减少(12.20%对9.76%,RR = 1.250,95% CI:0.520 - 3.007,P = 0.617)。注入ACP后未观察到不良反应。
本研究表明,在治疗息肉、肌瘤和子宫纵隔时,使用ACP凝胶似乎可降低宫腔粘连倾向和美国生育协会(AFS)评分,并提高宫腔镜电切术后的后续妊娠率。对于此类手术后预防宫腔粘连,可能推荐使用ACP。应开展纳入更多参与者的进一步研究。
中国临床试验注册中心ChiCTR2100047165